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Abstract Bacterial infections are common in cirrhosis
and can lead to life-threatening complications. Sidestream
dark-ﬁeld (SDF) imaging has recently emerged as a non-
invasive tool for capturing real-time video images of
sublingual microcirculation in critically ill patients with
sepsis. The objective of this study was to assess the utility
of SDF in determining underlying infection in patients with
cirrhosis. Sublingual microcirculation was compared
among patients with compensated cirrhosis (Group A,
n = 13), cirrhosis without sepsis (Group B, n = 18), cir-
rhosis with sepsis (Group C, n = 14), and sepsis only
(Group D, n = 10). The blood ﬂow was semi-quantita-
tively evaluated in four equal quadrants in small (10–
25 mm); medium (26–50 mm); and large (51–100 mm)
sublingual capillaries. The blood ﬂow was described as no
ﬂow (0), intermittent ﬂow (1), sluggish ﬂow (2), and con-
tinuous ﬂow (3). The overall ﬂow score or microvascular
ﬂow index (MFI) was measured for quantitative assessment
of microcirculation and predicting power for concurrent
infection in cirrhosis. Marked impairment was observed at
all levels of microvasculature in Groups B and C when
compared with Group A. This effect was restricted to small
vessels only when Group B was compared with Group C.
MFI\1.5 was found to have highest sensitivity (100%)
and speciﬁcity (100%) for infection in decompensated
cirrhosis. SDF imaging of sublingual microcirculation can
be a useful bedside diagnostic tool to assess bacterial
infection in cirrhosis.
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Introduction
Bacterial infections are major causes of morbidity and
mortality in cirrhosis [1, 2]. Cirrhosis is associated with
alterations in gut motility, bacterial ﬂora, and intestinal
permeability, thus favoring bacterial translocation [3]. As a
consequence, endotoxemia has been noted in cirrhosis
without infection [4]. More recently, high plasma levels of
TNF-a, IL1-b, IL6, and soluble adhesion molecules have
been demonstrated in decompensated cirrhosis, further
supporting the presence of an on-going inﬂammatory
response in this patient population [5–8].
Microcirculatory function is the main prerequisite for
adequate tissue oxygenation during infection or sepsis [9,
10]. As microcirculation is the primary site of oxygen and
nutrient exchange, the persistence of microcirculatory
dysfunction can lead to tissue hypoxia, organ failure, and
death. Thus, monitoring microcirculation is regarded as a
valuable tool in assessing the severity of the disease and
predicting its outcome [11]. This phenomenon has not yet
been studied in patients with cirrhosis.
Recent developments in new medical imaging tech-
niques have helped to discover microcirculation as a key
M. Y. Sheikh (&)  J. Choudhury  O. Deen  K. Dhah
Division of Gastroenterology and Hepatology, University of
California San Francisco-Fresno Medical Education Program,
Community Regional Medical Center, 2823 Fresno Street,
1st Floor, Endoscopy Suite, Fresno, CA 93721, USA
e-mail: msheikh@fresno.ucsf.edu
U. Javed
Division of Cardiology, University of California San Francisco-
Fresno Medical Education Program, Fresno, CA, USA
J. Singh  M. W. Peterson
Department of Internal Medicine, University of California San
Francisco-Fresno Medical Education Program, Fresno, CA, USA
123
Dig Dis Sci (2009) 54:2706–2711
DOI 10.1007/s10620-008-0664-5player in sepsis [12]. Several methods [12–19] have been
used to monitor microcirculatory function during circula-
tory failure in surgery and intensive care. Orthogonal
polarization spectral (OPS) imaging has enabled the ﬁrst
direct observation of the microcirculation of human inter-
nal organs [18, 19]. More recently, sidestream dark-ﬁeld
(SDF) imaging has emerged as a next-generation nonin-
vasive bedside tool that provides high contrast and real-
time video images of the microcirculation in critically ill
patients with sepsis [9, 12, 20, 21].
This prospective study was designed to assess changes
in the sublingual microcirculation with SDF video imaging
in decompensated cirrhosis with and without infection. The
primary goal was to determine whether sublingual micro-
circulatory changes could be a diagnostic tool to identify
infection in cirrhosis.
Methods
Patients
We enrolled 55 consecutive patients between 18 and
65 years with cirrhosis due to common etiologies over six
months at our institution. Patients were categorized into
four groups as follows:
A. 14 patients with compensated cirrhosis without
infection
B. 18 patients with decompensated cirrhosis without
clinical infection or sepsis
C. 13 patients with decompensated cirrhosis and infec-
tion or sepsis
D. 10 patients with sepsis but without cirrhosis.
All subjects in Groups C and D were hospitalized
patients whereas subjects in Groups A and B were all
outpatients. None of the Group A and Group B patients was
on antibiotic therapy at the time of enrollment or had
clinical evidence of any infection. In Groups C and D,
video imaging of microcirculation was accomplished
within 48 h of admission and initiation of antibiotic ther-
apy. Baseline characteristics for each subgroup were
assessed, including platelet counts, and Child–Turcotte–
Pugh (CTP) and model of end-stage liver disease (MELD)
scores (Table 1). Sepsis was identiﬁed on the basis of
American College of Chest Physicians/Society of Critical
Care Medicine consensus conference criteria [22]. Patients
with alcoholic hepatitis, pregnancy, HIV, hypotension
(systolic blood pressure\90 mmHg), DIC, acute myocar-
dial infarction, congestive heart failure, chronic renal
failure, malignancies, and hypercoagulable states were
excluded.
Methodology
All evaluations of microvascular ﬂow were performed by
the same two investigators (OD and KD) as described by
De Backer et al. [20] and Boerma et al. [21]. In Groups C
and D, microvascular ﬂow was evaluated within 48 h of
admission. A small probe (MicroScan; MicroVisionMedi-
cal) was placed under the tongue and streaming images of
the microcirculation were obtained and stored on digital
videotape (Sony Video Walkman GV-D 1000E). As het-
erogeneity of ﬂow has been postulated to be an important
characteristic of microvascular alterations during sepsis
[23], multiple video clips were obtained from three dif-
ferent sublingual locations. At least three good-quality
sequences of 20 s were taken from each site of interest. Of
each individual video clip, the best quality segment was
selected for semi-quantitative analysis of microvascular
ﬂow. The selection of video segments was dependent on
image quality (to avoid saliva, air bubbles, and pressure
artifacts).
Table 1 Baseline characteristics of patients
Group A
N = 14
Group B
N = 18
Group C
N = 13
Age (years)
Mean 40 55 54
Gender
Male 9 11 7
Female 5 7 6
Race
Hispanic 13 17 13
White 1 – –
Other – 1 –
MELD score
Range 7–10 8–16 10–29
Mean 8 12 20
CTP score
Range 5–7 7–11 9–12
Mean 6 8 11
Platelets count
Range 100–208 50–170 41–89
Mean 150 110 65
Etiology
HCV 3 5 2
Alcohol 3 8 3
Both 3 4 4
Other 5 1 4
Group A, compensated cirrhosis; Group B, decompensated cirrhosis
without infection/sepsis; Group C, decompensated cirrhosis with
infection/sepsis
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Each image was divided into four equal quadrants (I, II, II,
and IV) (Fig. 1). Quantitative ﬂow was scored per quad-
rant, for each cohort of vessel diameter. Microvascular
ﬂow was quantiﬁed by observation as no ﬂow (0, no ﬂow
for 20 s), intermittent ﬂow (1, greater than 10 s with no
ﬂow), sluggish ﬂow (2, less than 10 s with no ﬂow), and
continuous ﬂow (3, continuous ﬂow for 20 s). If a quadrant
contained different types of vessel with different diameters
(e.g. the sublingual vascular bed), these quantiﬁcations of
ﬂow were made according to the cohort of vessel diameter:
small (10–25 lm); medium (26–50 lm); and large, (51–
100 lm).
The overall score, called the microvascular ﬂow index
(MFI), was obtained as the sum of each quadrant score
divided by the number of quadrants in which the vessel
type was visible. MFI was quantiﬁed by two independent
observers (UJ and JS), who were unaware of patient
information. When there was a disagreement between these
two observers, the same third observer (MYS) reviewed the
images for quantiﬁcation of MFI. Inter-observer and intra-
observer disagreement was 12 and 10%, respectively. For
each subject, MFI was calculated on the basis of the four
quadrants of three video clips from three areas of interest.
Statistical Analysis
MFI was measured for small, medium, and large capillaries.
The mean for each group was used to perform a subgroup
analysis. The data from the four groups were tested using
ANOVA and, ﬁnally, all four groups were compared by use
of Bonferroni corrections (Tables 2 and 3).
Results
Mean patient age in compensated and decompensated cir-
rhosis was 40 and 55 years, respectively. Most patients
(98%) were Latinos and the most common causes of cir-
rhosis were alcohol and chronic hepatitis C. The underlying
infections in Group C were spontaneous bacterial perito-
nitis (ﬁve patients), cellulitis (three patients), community-
acquired pneumonia (three patients), acute osteomyelitis
(one patient), and salmonella bacteremia (one patient). The
mean MELD scores were 8, 12, and 20 for Groups A, B,
and C respectively. An increase in MELD and CTP scores
and a decline in platelet counts from Groups A to C
reﬂected the severity of liver disease (Table 1). The values
for Groups A (2.5 ± 0.2 SD, CI 2.3–2.6), B (1.5 ± 0.3 SD,
CI 1.3–1.8), and C (1.2 ± 0.2 SD, CI 1.0–1.4.) are listed in
Table 2. Only Group A (compensated cirrhosis) differed
from the other groups (Table 3). Microcirculation impair-
ment was most noticeable in the small capillaries,
irrespective of study group. Microcirculatory ﬂow was
signiﬁcantly impaired in all capillary beds in Group B
(decompensated cirrhosis) (P\0.001) and C (decompen-
sated cirrhosis with infection) (P\0.001) when compared
with Group A. Groups B and C differed only at the small
capillary level (P\0.033). Neither Group B nor Group C
Fig. 1 Sidestream dark-ﬁeld
video imaging demonstrating
blood ﬂow in a cirrhosis patient
with infection. The blood is
measured in various sized
capillaries in four quadrants of
the video clip
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bed. Mean microvascular ﬂow index (MFI) between 1.0
and 1.5 best predicted underlying infection in cirrhosis with
sensitivity and speciﬁcity approaching 100% (Table 4).
Discussion
We used SDF video imaging of microcirculation for the
ﬁrst time in cirrhosis to assess infections. Our study dem-
onstrated that the sublingual microcirculation in
decompensated cirrhosis mimics changes seen in sepsis but
with less intensity. These ﬁndings suggest that similar
mechanisms might exist in decompensated cirrhosis with-
out clinical infection. Alterations in gut bacterial ﬂora,
bacterial translocation [4] deﬁcient phagocytosis [23],
lower complement levels [24], poor opsonization, and
impaired serum bacteriocidal activity [25] all contribute to
increased susceptibility to infection in cirrhosis. High
plasma levels of tumor necrosis factor a (TNF-a) inter-
leukin (IL)-1, IL-6, and soluble adhesion molecules have
recently been demonstrated in decompensated cirrhosis
[26, 27]. In addition, patients with cirrhosis show high
plasma concentrations of endothelin (ET), and the levels
correlate with disease severity and ascites [27]. Therefore,
patients with decompensated cirrhosis are in the state of
endotoxemia without overt infection [28]. This endotoxe-
mia, with cytokine activation, ET release, and other
hormonal changes, could contribute signiﬁcantly to vaso-
constriction in the setting of arteriovenous shunting seen in
decompensated cirrhosis. In clinical bacterial infection,
larger concentrations of endotoxins, cytokines, ET-1, cat-
echolamines, and angiotensin II are produced. The
resulting net vasoconstriction leads to hypoxia, which is
also a driving force for ET-1 release. It is very likely
that overall ET receptor stimulation depends on the
relative balance between the competing vasodilator and
Table 2 Microvascular ﬂow index (MFI) in the four study groups in
relation to vessel size
Vessel Group MFI (mean ± SD) 95% CI
Small A 2.40 ± 0.46 2.07–2.73
B 1.40 ± 0.52 1.03–1.77
C 0.80 ± 0.48 0.45–1.15
D 1.15 ± 0.34 0.45–1.39
Medium A 2.35 ± 0.42 2.05–2.64
B 1.40 ± 0.32 1.17–0.62
C 1.25 ± 0.48 0.90–0.59
D 1.55 ± 0.28 1.34–0.75
Large A 2.75 ± 0.35 2.50–3.00
B 1.90 ± 0.77 1.35–0.45
C 1.65 ± 0.47 1.31–1.99
D 2.10 ± .52 1.73–0.47
Mean
a A 2.50 ± 0.21 2.35–2.64
B 1.56 ± 0.35 1.31–1.81
C 1.23 ± 0.24 1.06–1.40
D 1.60 ± 0.32 1.37–1.82
Group A, compensated cirrhosis; Group B, decompensated cirrhosis
without infection/sepsis; Group C, decompensated cirrhosis with
infection/sepsis; Group D, sepsis without cirrhosis
a Mean of all vessel types in an individual study group
Table 3 Comparison of microvascular ﬂow index (MFI) among
various study groups
Vessel type Group Mean MFI difference P
Small A vs. B 1.00 \0.0001
A vs. C 1.60 \0.0001
A vs. D 1.25 \0.0001
B vs. C 0.60 .033
B vs. D 0.25 1.000
C vs. D 0.35 .561
Medium A vs. B 0.95 \0.0001
A vs. C 1.10 \0.0001
A vs. D 0.80 \0.0001
B vs. C 0.15 1.000
B vs. D 0.15 1.000
C vs. D 0.30 .529
Large A vs. B 0.85 0.009
A vs. C 1.10 \0.0001
A vs. D 0.65 .074
B vs. C 0.25 1.000
B vs. D 0.20 1.000
C vs. D 0.45 .458
Mean
a A vs. B 0.93 \0.0001
A vs. C 1.27 \0.0001
A vs. D 0.90 \0.0001
B vs. C 0.33 .077
B vs. D 0.03 1.000
C vs. D 0.37 .501
Group A, compensated cirrhosis; Group B, decompensated cirrhosis
without infection/sepsis; Group C, decompensated cirrhosis with
infection/sepsis; Group D, sepsis without cirrhosis
a Mean of all vessel types in an individual study group
Table 4 Discriminatory power of microvascular ﬂow index (MFI)
for infection/sepsis at various cut-off levels
MFI cut off Sensitivity Speciﬁcity PPV NPV
\1.0 90 100 100 91
\1.5 100 100 100 100
\2.0 100 50 60 100
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123vasoconstrictor forces [29, 30]. The balance is ultimately
tipped in the favor of vasoconstrictors in advanced cir-
rhosis and associated infection.
Blood ﬂow through capillaries is quite different from that
through arterioles and venules. Exchange of metabolites
and transport through the vessel wall is only possible in the
capillaries, because only here is the blood ﬂow sufﬁciently
reduced (about 0.3 mm/s) and the vessel wall sufﬁciently
thin. The arterioles are of larger diameter (B50 lm) and are
responsible for vascular resistance. Arteriovenous shunts
formed in advanced cirrhosis cause some diversion of blood
ﬂow away from the true capillaries, thus affecting micro-
circulation [31, 32]. In addition, impaired red cell
deformability has been found in patients with cirrhosis and
sepsis. This increased rigidity of the red cells could, in part,
explain the AV shunting and decreased microcirculatory
ﬂow seen in both cirrhosis and sepsis [33]. We believe that
the changes we found in medium and small capillaries in
decompensated cirrhosis could also be the result of AV
shunting and impaired red cell deformability.
When compared with the Group B patients, Group C
patients had higher MELD and CTP scores and evidence of
clinical infection. For these patients a profound impact on
their microcirculation was observed at the smaller capillary
levels (D MFI 0.6, P = 0.03.). Hardly any ﬂow was noticed
in these smaller capillaries. Therefore, MFI\1.5 repre-
sented the most sensitive and speciﬁc tool for detecting
infection (Table 4). These vascular changes could repre-
sent the cumulative effects of increasing cytokines, ET, and
other vasoconstrictors in the presence of worsening
hemodynamics of advanced cirrhosis. With infection, we
expect a further rise in these cytokines that can aggravate
vascular resistance and consequent decreased perfusion.
The cytokines may also decrease nitric oxide release and
endothelial-dependent relaxation noted in smaller vessels
[34]. Besides vasoconstriction, the accumulation and
adherence of leukocytes to the vascular wall seen in sepsis
[35] may worsen microcirculation. Tissue hypoxia can
further induce an inﬂammatory response within the vessel
wall, and the recruited circulating progenitor cells could
contribute signiﬁcantly to the structural remodeling and
persistent vasoconstriction [36]. In addition to CTP and
MELD scores, hemodynamic changes in patients with
cirrhosis correlate with their prognosis [37]. Our study
supports a good correlation between these scores and mi-
crocirculatory changes.
Despite many interesting observations made through a
selected group of patients, our study has many limitations.
First, the number of subjects in the study groups (B and C)
was relatively small. Second, Group C had heterogeneous
infections. Third, microcirculation was assessed 24–48 h
after initiation of antibiotic therapy that might have
improved patients’ clinical sepsis in Group C. The latter
might have affected our ﬁndings, which would have been
signiﬁcantly worse if microcirculation had been assessed at
the time of patients’ initial presentation. Fourth, invasive
hemodynamic data and other hormonal factors for these
patients were not assessed and in future, larger studies may
have to address the need for such monitoring in the context
of this technique.
As sepsis in cirrhosis is associated with complications
such as encephalopathy, gastrointestinal bleed, and renal
failure, the observations noted in our study raise several
interesting questions. Does hypoxia induced by impaired
systemic circulation aggravate hepatic encephalopathy
seen in patients with worsening liver disease or infection?
Do worsening microcirculatory changes predict advancing
cirrhosis, portal hypertension, or hepatorenal syndrome?
Are systemic microcirculatory changes reversible with
antibiotic therapy with or without albumin infusion? Pro-
spective studies are currently needed to establish such
relationships in a larger patient population.
In conclusion, our study has demonstrated that the
microcirculation is affected in both cirrhosis and in sepsis
without liver disease. These microcirculatory changes in
decompensated cirrhosis with overt infection are pro-
foundly impaired and can be detected noninvasively by
assessing sublingual microcirculation at bedside. This
method of monitoring microcirculation at the bedside in
cirrhotics has great potential in overall management of this
complex disorder. Early non-invasive monitoring of
microcirculation in infections such as spontaneous bacte-
rial peritonitis can help physicians to decide the timing of
initiation of antibiotic therapy and thus prevent life-
threatening complications of cirrhosis. Larger studies are
needed to further assess the validity of sublingual imaging
of microcirculation in cirrhosis with infection before and
after therapeutic intervention.
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